title: Incidence of rash and discontinuation of nevirapine using two different escalating initial doses.
authors: P
authors: P
authors: Antón
authors: V
authors: V
authors: Soriano
authors: I
authors: I
authors: Jiménez-Nácher
authors: R
authors: R
authors: Rodriguez-Rosado
authors: M C
authors: MC
authors: Dona
authors: P M
authors: PM
authors: Barreiro
authors: J
authors: J
authors: González-Lahoz
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005076:Exanthema / Q000150:complications / Q000453:epidemiology*; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D015497:HIV-1; D006801:Humans; D015994:Incidence; D019829:Nevirapine / Q000009:adverse effects* / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine